Identification
Personal identification
- Full name
- Maria João Nunes
Citation names
- Nunes, Maria João
- Nunes, MJ
Author identifiers
- Ciência ID
- F817-6C0A-3AFF
- ORCID iD
- 0000-0002-4922-633X
- Researcher Id
- F-6766-2015
- Scopus Author Id
- 58724016200
Email addresses
- mariajoaonunes@ff.ulisboa.pt (Professional)
Telephones
- Fax
-
- 217946491 (Professional)
- Telephone
-
- 217946496 (Professional)
Addresses
- iMed.ULisboa, Faculty of Pharmacy, Universidade de Lisboa. Av. Prof Gama Pinto, 1649-003, Lisbon, Lisbon, Portugal (Professional)
Websites
- https://imed.ulisboa.pt/members/maria-joao-de-jesus-nunes/ (Professional)
- https://www.ff.ulisboa.pt/team/maria-joao-de-jesus-nunes/?lang=en (Professional)
Knowledge fields
- Medical and Health Sciences - Basic Medicine - Neurosciences
Languages
Language | Speaking | Reading | Writing | Listening | Peer-review |
---|---|---|---|---|---|
English | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) | Proficiency (C2) |
Portuguese (Mother tongue) |
Education
Degree | Classification | |
---|---|---|
2014/10/06 - 2014/10/17
Concluded
|
XIII Course on Laboratory Animal Science - FELASA Level C (Pós-Graduação)
Universidade de Lisboa Faculdade de Medicina Veterinária, Portugal
|
|
2008 - 2012
Concluded
|
Farmácia (Doutoramento)
Major in Molecular and Celular Biology
Universidade de Lisboa Faculdade de Farmácia, Portugal
"Transcriptional regulatory mechanisms involved in CYP46A1 up-regulation by histone deacetylase inhibitors - from chromatin
structure to transcription factors" (THESIS/DISSERTATION)
|
Approved, with honour and laureate |
2000 - 2005
Concluded
|
Química Aplicada (Licenciatura)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
"Quantificação de expressão génica através de nanopartículas de ouro coloidal" (THESIS/DISSERTATION)
|
16/20 |
Affiliation
Science
Category Host institution |
Employer | |
---|---|---|
2018/03 - Current | Researcher (Research) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal |
Others
Category Host institution |
Employer | |
---|---|---|
2014 - 2018/02 | Post-Doctoral Fellow (SFRH/BPD/95855/2013) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal | ||
2013 - 2013 | Research Fellow | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2008 - 2012 | PhD Student (SFRH/BD/41848/2007) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Projects
Grant
Designation | Funders | |
---|---|---|
2022/01 - 2024 | Redox-signaling modulation of mitochondrial dysfunction through post-translational modifications
Provided by PTCRIS: EXPL/BIA-BQM/0793/2021
Researcher
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2018 - 2022 | PGC-1alpha isoforms as novel therapeutic targets in Parkinson's disease
PTDC/MED-FSL/30104/2017
Researcher
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2018 - 2022 | CYP46A1 as a new therapeutic target in Niemann-Pick type C disease
PTDC/MED-NEU/29455/2017
Researcher
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Fundação para a Ciência e a Tecnologia
Ongoing
|
2013 - 2016 | S-Glutathionylation in Parkinson's Disease
PTDC/NEU-OSD/0502/2012
Post-doc Fellow
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2013 - 2016 | Unraveling the neuroprotective role of TUDCA in Parkinson's disease: targeting oxidative stress and mitophagy
PTDC/NEU-NMC/0248/2012
Post-doc
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2011 - 2014 | Control of neuronal signaling pathways by CYP46A1, an enzyme involved in brain cholesterol turnover
PTDC/SAU-NMC/110809/2009
Research Fellow
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Fundação para a Ciência e a Tecnologia
Concluded
|
2007/08 - 2010/12 | Estrogen signaling and epigenetic modifications in the regulation of the CYP46A1 expression in the brain
PhD Student Fellow
|
Fundação para a Ciência e a Tecnologia |
2007/01 - 2009/10 | Molecular mechanisms involved in the transcriptional regulation of the human CYP46 gene - Implications in brain cholesterol
homeostasis.
Research Fellow
|
Fundação para a Ciência e a Tecnologia |
Outputs
Publications
Conference abstract |
|
Journal article |
|
Thesis / Dissertation |
|
Activities
Oral presentation
Presentation title | Event name Host (Event location) |
|
---|---|---|
2024/04/04 | Nunes MJ, Carvalho AN, Sá-Lemos C, Colaço M, Cervenka I, Ciraci V, Santos SG, Ribeiro MM, Castanheira M, Jannig PR, Gama MJ, Castro-Caldas M, Rodrigues CMP, Rodrigues E and Ruas JL. Role of PGC-1a2 and PGC-1a3 isoforms in astrocyte function: impact on neurodegeneration. 8th Symposium PT Glial Network. | 8th Symposium PT Glial Network
Portuguese Glial Network (Braga, Portugal)
|
2023 | Nunes MJ. Role of PGC1a2 and PGC1a3 isoforms in astrocyte function: impact on neurodegeneration | imed Seminar – The Young Investigator Series
iMed.ULisboa, Faculty of Pharmacy, University of Lisbon
|
2023 | Nunes MJ, Carvalho AN, Reis J, Costa D, Moutinho M, Mateus J, Mendes de Almeida R, Brito S, Risso D, Castro-Caldas M, Gama MJ, Rodrigues CMP, Xapelli S, Diógenes MJ, Cartier N, Piguet F and Rodrigues E. Restoring cholesterol homeostasis in neurons by AAV-mediated CYP46A1 delivery is not sufficient to stall the progression of Niemann-Pick type C disease. 19th International Symposium of the Portuguese Society for Metabolic disorders (Best oral communication award) | 19th International Symposium of the Portuguese Society for Metabolic disorders.
(Figueira da Foz, Portugal)
|
2022 | Kovalchuk DA, Caria I, Anjo SI, Branco V, Nunes MJ, Castro-Caldas M, Rodrigues E, Guedes RC, Manadas B, Gama MJ and Carvalho NA. Redox-signaling regulation of mitochondrial dynamics and function through post-translational modifications. | EMBO practical course “Characterisation of post-translational modifications in cellular signalling” |
2022 | Matos PP, Nunes MJ, Rodrigues E; Silva LC. NPC1 cells present altered membrane properties and heterogeneous lysosomal population. 2nd Workshop on Sphingolipids in Health and Disease. | 2nd Workshop on Sphingolipids in Health and Disease
(Aveiro, Portugal)
|
2021/06/07 | Nunes MJ, Carvalho A, Costa D, Mendes de Almeida R, Risso D, Brito S, Mateus J, Xapelli S, Diógenes MJ, Piguet F, Gama MJ, Castro-Caldas M, Cartier N and Rodrigues E. CYP46A1 ectopic expression corrects pathological cholesterol accumulation in Npc1tm(I1061T) mice cerebellum. | 2021 Michael, Marcia and Christa Parseghian Scientific Conference for Niemann-Pick Type C Research - Virtual Symposiums
The Ara Parseghian Medical Research Fund
|
2020 | Caria I, Nunes, MJ, Carvalho AN, Castro-Caldas M, Gama MJ, Rodrigues E and Ruas JL. Inhibition of the mitochondrial complex I by a Parkinson's Disease-inducing neurotoxin leads to a NPC1 phenotype in neuronal cells. 16th International Symposium of the Portuguese Society of Metabolic Disorders Honorable Mention Award. | 16th International Symposium of the Portuguese Society of Metabolic Disorders. |
2019 | Costa D, Moutinho M, Nunes MJ, Silva MF, Mendes de Almeida R, Carvalho AN, Castro-Caldas M, Gama MJ, Rodrigues CM and Cartier N, Rodrigues E. CYP46A1 expression modulates mitochondrial function and integrity in Niemann-Pick type C disease. XVI Congresso da Sociedade Portuguesa de Neurociências (SPN2019). |
(Lisbon, Portugal)
|
2019 | Nunes MJ, Costa D, Mendes de Almeida R, Castro-Caldas M, Gama MJ and Rodrigues E. Identification of HDACs involved in the control of brain cholesterol metabolism. The 7th Mediterranean Neuroscience Conference. |
(Marrakech, Morocco)
|
2019 | Nunes MJ. Targeting brain cholesterol metabolism as a therapeutic approach: from neurodegeneration to cancer | Post-Doc Seminar Series, iMed.ULisboa |
2018 | Rosa AI, Duarte-Silva S, Silva-Fernandes A, Nunes MJ, Carvalho AN, Rodrigues E, Gama MJ, Rodrigues CMP, Maciel P, Castro-Caldas M. Tauroursodeoxycholic acid improves motor symptoms in a mouse model of Parkinson's disease. Congresso Sociedade Portuguesa de Doenças do Movimento 2018 - Genética nas Doenças do Movimento. |
(Curia, Portugal)
|
2017 | Nunes MJ, Moutinho M, Costa D, Castro-Caldas M, Gama MJ, Rodrigues CMP and Rodrigues E. CYP46A1 as a therapeutic target in neurodegenerative disorders with altered brain cholesterol homeostasis. 1.ª Conferência Anual da Rede Saúde. |
(Lisbon, Portugal)
|
2015 | Moreira S, Fonseca I, Silva-Azevedo C, Nunes MJ, Gama MJ, Rodrigues E, Rodrigues CMP and Castro-Caldas M, [Ferreira Mendes A.]. Nrf2 regulation by TUDCA in a mouse model of Parkinson’s disease. XLV SPF Meeting. |
(Lisbon, Portugal)
|
2015 | Silva-Azevedo C, Carvalho AN, Santos M, Nunes MJ, Rodrigues E, Castro-Caldas M and Gama MJ. TUDCA modulates the ER stress response in the brain of C57BL/6 mice. XLV SPF Meeting. |
(Lisbon, Portugal)
|
2015 | Moutinho M, Nunes MJ, Gama MJ, Rodrigues CMP, Björkhem I, Ruas JL and Rodrigues E. CYP46A1 as a putative target for diabetes-induced brain dysfunction. SRP Diabetes Retreat. |
(Stockholm, Sweden)
|
2015 | Moutinho M, Nunes MJ, Gama MJ, Rodrigues CMP, Björkhem I, Ruas JL and Rodrigues E. Neuronal cholesterol metabolism induces dendritic outgrowth and synaptic function by regulating Trk-GGTase-I interaction. 7th iMed.ULisboa Post-Graduate Students Meeting. |
(Lisbon, Portugal)
|
2015 | Moutinho M, Nunes MJ, Gama MJ, Rodrigues CMP, Björkhem I, Ruas JL and Rodrigues E. Neuronal cholesterol metabolism activates GGTase-I and Trk increasing dendritic outgrowth and protrusion density. 1º Encontro de Alunos de Doutoramento do Colégio Mente-Cérebro da Universidade de Lisboa. |
(Lisbon, Portugal)
|
2014 | Moreira S, Fonseca I, Silva-Azevedo C, Nunes MJ, Gama MJ, Rodrigues E, Rodrigues CMP, Castro-Caldas M. Nrf2 regulation by TUDCA in a mouse model of Parkinson's disease. Annual Meeting of the Portuguese Society of Pharmacology. |
(Lisbon, Portugal)
|
2014 | Fonseca I, Moreira S, Silva-Azevedo C, Nunes MJ, Gordino G, Gama MJ, Rodrigues E, Rodrigues CMP and Castro-Caldas M. Mechanisms involved in TUDCA-dependent neuroprotection: Is mitophagy involved? Annual Meeting of the Portuguese Society of Pharmacology. |
(Lisbon, Portugal)
|
2014 | Moutinho M, Nunes MJ, Gama MJ, Rodrigues CMP, Björkhem I and Rodrigues E. CYP46A1 increases neuronal development and the content of synaptic proteins in a prenylation-dependent manner. 4th European Network for Oxysterols Research (ENOR) Symposium: Translational Research on Oxysterols. |
(Coimbra, Portugal)
|
2013 | Moutinho M, Nunes MJ, Gama MJ, Rodrigues CMP and Rodrigues E. CYP46A1 overexpression enhances sGTPases membrane association and consequently inhibits the LXR pathway in neurons. 54th International Conference on the Bioscience of Lipids: Linking Transcription to Physiology in Lipidomics. |
(Bari, Italy)
|
2013 | Nunes MJ, Milagre I, Moutinho M, Gama MJ and Rodrigues E. Retinoic acid represses CYP46A1 gene transcription by inducing the recruitment of phosporylated ERK1/2 to the Sp3-rich proximal promoter. 54th International Conference on the Bioscience of Lipids: Linking Transcription to Physiology in Lipidomics. |
(Bari, Italy)
|
2012 | Nunes MJ, Moutinho M, Milagre I, Gama MJ and Rodrigues E. The usual suspects: How Sp3-ERK1/2 mediate the derepression of CYP46A1 gene by the histone deacetylase inhibitor trichostatin A. Portuguese RNA Meeting. |
(Lisbon, Portugal)
|
2012 | Nunes, MJ. CYP46A1 up-regulation by histone deacetylase inhibitors: from chromatin structure to transcription factors. Lisbon Area Neuroscience Meeting. Instituto de Medicina Molecular. |
(Lisbon, Portugal)
|
2012 | Nunes, MJ. CYP46A1 up-regulation by histone deacetylase inhibitors: from chromatin structure to transcription factors. Lisbon Chromatin Club: Autumn Session, Instituto Gulbenkian de Ciência. |
(Oeiras, Portugal)
|
2011 | Moutinho M, Nunes MJ, Milagre I, Gama MJ and Rodrigues E. Role of CYP46A1 in small GTPases isoprenylation. 25ª Reunião do Grupo de Estudos de Envelhecimento Cerebral e Demência. |
(Tomar, Portugal)
|
2011 | Nunes MJ, Milagre I, Castro-Caldas M, Moutinho M, Gama MJ and Rodrigues E. Neuronal differentiation alters the ratio of Sp transcription factors recruited to the CYP46A1 promoter. 25ª Reunião do Grupo de Estudos de Envelhecimento Cerebral e Demência. |
(Tomar, Portugal)
|
2011 | Nunes MJ, Moutinho M, Milagre I, Gama MJ and Rodrigues E. The usual suspects: How Sp3-ERK1/2 mediate the inhibitory effect of okadaic acid treatment in the derepression of CYP46A1 gene by the histone deacetylase inhibitor trichostatin A. 3rd iMed.UL Post-Graduate Students Meeting. |
(Lisbon, Portugal)
|
2011 | Nunes MJ, Milagre I, Castro-Caldas M, Moutinho M, Gama MJ and Rodrigues E. Neuronal differentiation alters the ratio of Sp transcription factors recruited to the CYP46A1 promoter. 17th International Conference on Cytochrome P450. |
(Manchester, United Kingdom)
|
2010 | Milagre I, Nunes MJ, Moutinho M, Rivera I, Fuso A, Scarpa S, Gama MJ, Rodrigues E. Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination. 24ª Reunião do Grupo de Estudos de Envelhecimento Cerebral e Demência. |
(Tomar, Portugal)
|
2010 | Moutinho M, Nunes MJ, Milagre I, Gama MJ, Rodrigues E. CYP46A1 induction by HDAC inhibitors depends on protein phosphatase 2a activity. 24ª Reunião do Grupo de Estudos de Envelhecimento Cerebral e Demência. |
(Tomar, Portugal)
|
2010 | Nunes MJ, Milagre I, Moutinho M, Castro-Caldas M, Gama MJ, Rodrigues E. Cross-talk between RARg and Sp transcription factors is responsible for repression of CYP46A1 gene expression by retinoic acid. 24ª Reunião do Grupo de Estudos de Envelhecimento Cerebral e Demência. |
(Tomar, Portugal)
|
2010 | Pinheiro A, Faustino I, Milagre I, Nunes MJ, Rodrigues E, Silva MJ, Tavares de Almeida I and Rivera I. PDH2 gene activation: could a testis-specific gene rescue the somatic energy metabolism? XVII Congresso Nacional de Bioquímica. |
(Porto, Portugal)
|
2010 | Milagre I, Nunes MJ, Moutinho M, Rivera I, Fuso A, Scarpa S, Gama MJ and Rodrigues E. Chromatin-modifying agents increase transcription of CYP46A1, a key player in brain cholesterol elimination. 2nd Post-Graduate iMed.UL Students Meeting. |
(Lisbon, Portugal)
|
2009 | Nunes MJ, Milagre I, Gama MJ and Rodrigues E. Sp proteins have a critical role in HDAC inhibitor-mediated derepression of CYP46A1 gene transcription. 23ª Reunião do Grupo de Estudos de Envelhecimento Cerebral e Demência. |
(Luso, Portugal)
|
2008 | Rodrigues E, Milagre I, Nunes MJ, Gama MJ and Rodrigues CM. Role of CYP46A1 in brain cholesterol homeostasis. 1st iMed.UL Meeting. |
(Lisbon, Portugal)
|
2008 | Rodrigues CMP, Gama MJ, Moreira da Silva IB, Rodrigues E, Solá S, Castro Caldas M, Castro RE, Ramalho RM, Nunes AF, Amaral JD, Borralho PM, Aranha MM, Viana RJS, Milagre I, Santos DM, Neves Carvalho A and Nunes MJ. Molecular and Cell Biology of Eukaryotic Systems. 1st iMed.UL Meeting. |
(Lisbon, Portugal)
|
2007 | Nunes MJ, Milagre I, Gama MJ, Silva R, Fernandes A, Lechner MC and Rodrigues E. The brain-specific SP4 transcription factor is a major regulator of the CYP46A1 gene. 21ª Reunião do Grupo de Estudos de Envelhecimento Cerebral e Demência. |
(Luso, Portugal)
|
Supervision
Thesis Title Role |
Degree Subject (Type) Institution / Organization |
|
---|---|---|
2022 - Current | CYP46A1-dependent regulation of neuronal intracellular traffic
Co-supervisor
|
Farmácia (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021/08/30 - 2022 | Restoring cholesterol homeostasis in neurons by CYP46A1 does not stall the progression of Niemann-Pick type C disease
Supervisor
|
Ciências Biofarmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021/08/30 - 2022 | New role of PGC-1a2 and PGC-1a3 isoforms in the control of astrocyte phenotype
Co-supervisor
|
Ciências Biofarmacêuticas (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2018 - 2020 | Unanswered role of cholesterol homeostasis in Parkinson’s Disease
Co-supervisor
|
Genética Molecular e Biomedicina (Master)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
2018 - 2019 | Identification of modulators of the transcriptional activity of SREBP transcription factors
Co-supervisor
|
Scientific Research Project Course III (Other)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
Event organisation
Event name Type of event (Role) |
Institution / Organization | |
---|---|---|
2019 - 2019 | 11th International Meeting of Portuguese Society for Stem Cells and Cell Therapy (2019/10/10 - 2019/10/12)
Meeting (Member of the Organising Committee)
|
Universidade de Lisboa Faculdade de Farmácia, Portugal |
2009 - 2009 | 1st iMed.UL Postgraduate Students Meeting (2009 - 2009)
Meeting (Member of the Organising Committee)
|
Universidade de Lisboa Faculdade de Farmácia, Portugal |
Event participation
Activity description Type of event |
Event name Institution / Organization |
|
---|---|---|
2010 - Current | International Brain Awareness Week (BAW) and Ciência Viva Initiatives - participated and co-organized the educational activities promoted by iMed.ULisboa/FFULisboa that include lectures, lab tours and classroom visits for the general public. Ciência Viva initiatives also include internships of high school students in the laboratories. | |
2018/07/10 - 2018/07/12 | MouseAGE (Development of a European network for preclinical testing of interventions in mouse models of age and age-related diseases) COST Action BM1402 training school: Behavioural Phenotyping in mice: Focus on longitudinal studies in ageing, Instituto de Investigaciones Biomédicas Alberto Sols. Madrid, Spain. | |
2017/07/13 - 2017/07/14 | Round table speaker: The PathAway: The Next Challenge, 9th iMed.ULisboa and 2nd i3du Postgraduate Students Meeting.
Round table
|
|
2015/11/23 - 2015/11/25 | MouseAGE (Development of a European network for preclinical testing of interventions in mouse models of age and age-related diseases) COST Action BM1402 training school: Creating and Phenotyping Mouse models of Disease and Aging, MRC Harwell. Oxfordshire, UK. |
Jury of academic degree
Topic Role |
Candidate name (Type of degree) Institution / Organization |
|
---|---|---|
2024/03/14 | Exploring the Role of Sacsin and S100B proteins in Cytoskeleton Organization
(Thesis) Main arguer
|
Ana Sofia Boasinha Ribeiro (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal
|
2023/09/23 | Lipid Alterations in Parkinson’s Disease
(Thesis) Main arguer
|
Laura Preciado (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2022 | Doença de Gaucher e Doença de Parkinson: Identificação dos mecanismos subjacentes a duas patologias distintas
(Thesis) Main arguer
|
Duarte Riachos (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2022 | O papel do PGC-1a na regulação bioenergética e função neuronal
(Thesis) Main arguer
|
Julie Oliveira (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021/12/21 | The role of CDKs in co-trancriptional splicing through phosphorylation of the RNA pol II carboxy-terminal domain (CTD)
(Thesis) Arguer
|
Thais Souza Cunha (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2021/09/29 | PGC-1a: a target for neurodegenerative disorders
(Thesis) Arguer
|
Mariana da Costa Pereira (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2020/11/24 | Glucose intestinal absorption: A promising target for dietary proteins and Metformin
(Thesis) Arguer
|
Joana Filipa Borrega Moura Lourenço (Master)
Universidade de Lisboa Faculdade de Farmácia, Portugal
|
2018 | ZNF675 evolutionary history and its novel role in neuronal regulatory networks
(Thesis) Main arguer
|
Rita Leonor Franco Paulo Guimarães (Master)
Universidade Nova de Lisboa Faculdade de Ciências e Tecnologia, Portugal
|
Course / Discipline taught
Academic session | Degree Subject (Type) | Institution / Organization | |
---|---|---|---|
2022 - Current | PhD Advanced Course Molecular Biomarkers and Technologies | (Curso de doutoramento (conclusão de unidades curriculares)) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2021 - Current | Molecular Biology curricular unit | Ciências Farmacêuticas (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2018 - Current | Pharmacogenomics curricular unit | Ciências Farmacêuticas (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2018 - Current | Pharmacogenetics curricular unit | Ciências Biofarmacêuticas (Mestrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2018 - 2020 | Biochemistry II curricular unit | Ciências Farmacêuticas (Mestrado integrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
2010 - 2017 | Eukaryotic Gene Regulation and Functional Genomics curricular unit | Ciências Biofarmacêuticas (Mestrado) | Universidade de Lisboa Faculdade de Farmácia, Portugal |
Distinctions
Award
2011 | Travel award to attend the 17th International Conference on Cytochrome P450 in Manchester, UK.
The University of Manchester - North Campus, United Kingdom
|